Paris Daily Reporter
SEE OTHER BRANDS

Following the news from France

Paris Daily Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Paris Daily Reporter.

Press releases published on July 30, 2025

RFCLA and San Diego Legion Unite to Form 'The California Legion'

RFCLA and San Diego Legion Unite to Form 'The California Legion'

San Diego Legion and Rugby Football Club Los Angeles (RFCLA) will unite to create The California Legion, a newly formed professional rugby team. LOS ANGELES, CA, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- San Diego Legion and Rugby Football …

NoPayn Scales High-Risk Payment Gateway with Lean Team and Global Reach

NoPayn Scales High-Risk Payment Gateway with Lean Team and Global Reach

Estonia-Based Fintech Introduces Streamlined Payment Infrastructure for Vape, CBD, Gambling, and Other High-Risk Industries ASNIèRES-SUR-SEINE, FRANCE, July 30, 2025 /⁨EINPresswire.com⁩/ -- NoPayn, a high-risk payment gateway founded by fintech …

Da Vinci Labs mène le tour d’amorçage de MS4ALL, la start-up qui révolutionne la simulation moléculaire

Da Vinci Labs mène le tour d’amorçage de MS4ALL, la start-up qui révolutionne la simulation moléculaire

Da Vinci Labs annonce sa prise de participation en tant qu'investisseur principal dans le tour d'amorçage de MS4ALL TOURS, FRANCE, July 30, 2025 /⁨EINPresswire.com⁩/ -- Da Vinci Labs, acteur engagé dans le soutien aux start-ups deeptech à impact positif, …

Enteral Feeding Devices Market to Reach $$9.8 Billion Globally by 2035, Growing At a CAGR of 6.7%

Enteral Feeding Devices Market to Reach $$9.8 Billion Globally by 2035, Growing At a CAGR of 6.7%

The market is driven by rise in geriatric population, surge in preterm birth, and rise in prevalence of chronic diseases. WILMINGTON, DE, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research published a report, titled, "Enteral …

FundedNext Launches AI Assistant 'Fundee', the First Prop Firm with Multilingual Voice AI Support

FundedNext Launches AI Assistant 'Fundee', the First Prop Firm with Multilingual Voice AI Support

Supports 32 Languages to Bridge Global Access and Cultural Relevance, Redefining Client Support with AI-Powered Assistance AJMAN, DUBAI, UNITED ARAB EMIRATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- FundedNext, a leading prop trading firm, launched its …

Agility Capital, Inc. Launches Investment Banking Platform For Restaurant & Real Estate Sectors

Agility Capital, Inc. Launches Investment Banking Platform For Restaurant & Real Estate Sectors

Agility Capital Holding (ENX:AGIL) TAMPA, FL, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Agility Capital Holding Inc. ("Agility") (Euronext: AGIL), via its wholly owned US subsidiary Agility Capital, Inc., is pleased to announce that it is now …

Eramet: Increased focus on operational efficiency following a highly pressured H1 2025

Eramet: Increased focus on operational efficiency following a highly pressured H1 2025

Paris, 30 July 2025, 6:30 p.m. PRESS RELEASE Eramet: Increased focus on operational efficiency following a highly pressured H1 2025 Safety performance remained strong in H1 2025, with a Group TRIFR1 of 0.6 Adjusted EBITDA (excluding SLN)2 at €191m, down …

Eramet : priorité à l’efficacité opérationnelle après un 1er semestre 2025 sous forte pression

Eramet : priorité à l’efficacité opérationnelle après un 1er semestre 2025 sous forte pression

Paris, le 30 juillet 2025, 18h30 COMMUNIQUE DE PRESSE Eramet : priorité à l’efficacité opérationnelle après un 1er semestre 2025 sous forte pression Solide performance en matière de sécurité au S1 2025, avec un TF21 Groupe de 0,6 EBITDA ajusté (hors SLN)2 …

Atos successfully delivered its full suite of Digital Services, including its new AI-powered Content Repository, to the European Youth Olympic Festival Skopje 2025.

Atos successfully delivered its full suite of Digital Services, including its new AI-powered Content Repository, to the European Youth Olympic Festival Skopje 2025.

                                                                News Atos successfully delivered its full suite of Digital Services, including its new AI-powered Content Repository, to the European Youth Olympic Festival Skopje 2025. Skopje, North …

Atos a livré avec succès sa gamme complète de services numériques, incluant son nouveau Centre Média enrichi par l'IA, lors du Festival Olympique de la Jeunesse Européenne de Skopje 2025

Atos a livré avec succès sa gamme complète de services numériques, incluant son nouveau Centre Média enrichi par l'IA, lors du Festival Olympique de la Jeunesse Européenne de Skopje 2025

                                                                News Atos a livré avec succès sa gamme complète de services numériques, incluant son nouveau Centre Média enrichi par l'IA, lors du Festival Olympique de la Jeunesse Européenne de Skopje 2025. …

happn unveils AI-powered tool to redefine date planning

happn unveils AI-powered tool to redefine date planning

PARIS, July 30, 2025 (GLOBE NEWSWIRE) -- Real-life dating app happn, has launched Perfect Date — a world-first generative AI feature powered by large language models (LLMs). It helps users move from chatting to meeting-up through tailored location …

Atos reconnu Supplier Engagement Leader par le CDP pour la 5ème fois

Atos reconnu Supplier Engagement Leader par le CDP pour la 5ème fois

                                        Communiqué de presse Atos reconnu Supplier Engagement Leader par le CDP pour la 5ème fois Paris, France – 30 juillet 2025 – Atos intègre, pour la 5ème fois, le prestigieux classement Supplier Engagement Rating …

Atos recognized as Supplier Engagement Leader by CDP for the 5th time

Atos recognized as Supplier Engagement Leader by CDP for the 5th time

                                                                     Press Release Atos recognized as Supplier Engagement Leader by CDP for the 5th time Paris, France – July 30, 2025 – Atos has been recognized for the fifth time by the Carbon Disclosure …

AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML

AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML

PRESS RELEASE AB SCIENCE RECEIVES REGULATORY APPROVAL FROM EUROPEAN COUNTRIES TO INITIATE THIRD STAGE OF PHASE I/II STUDY COMBINING ITS MOLECULE AB8939 WITH VENETOCLAX FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA THE COMBINATION OF AB8939 TARGETING …

AB Science a reçu l’approbation règlementaire de pays européens pour initier la troisième étape de la phase I/II visant à combiner sa molécule AB8939 avec le venetoclax dans le traitement de la LMA

AB Science a reçu l’approbation règlementaire de pays européens pour initier la troisième étape de la phase I/II visant à combiner sa molécule AB8939 avec le venetoclax dans le traitement de la LMA

COMMUNIQUÉ DE PRESSE AB SCIENCE A RECU L’APPROBATION REGLEMENTAIRE DE PAYS EUROPEENS POUR INITIER LA TROISIEME ETAPE DE LA PHASE I/II VISANT A COMBINER SA MOLÉCULE AB8939 AVEC LE VENETOCLAX DANS LE TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË LA COMBINAISON D’ …

Communiqué de presse: Le SAR446523 de Sanofi, un anticorps monoclonal anti-GPRC5D, se voit accorder la désignation médicament orphelin pour le myélome multiple aux États-Unis

Communiqué de presse: Le SAR446523 de Sanofi, un anticorps monoclonal anti-GPRC5D, se voit accorder la désignation médicament orphelin pour le myélome multiple aux États-Unis

Le SAR446523 de Sanofi, un anticorps monoclonal anti-GPRC5D, se voit accorder la désignation médicament orphelin pour le myélome multiple aux États-Unis Désignation accordée pour l’anticorps monoclonal GPRC5D à base d’immunoglobulines G pour le traitement …

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment of patients with relapsed or refractory multiple …

Nexans announces the departure of its Deputy Chief Executive  Officer and Chief Financial Officer. The Company has initiated the  search for a new Chief Financial Officer

Nexans announces the departure of its Deputy Chief Executive Officer and Chief Financial Officer. The Company has initiated the search for a new Chief Financial Officer

Nexans announces the departure of its Deputy Chief Executive Officer and Chief Financial Officer. The Company has initiated the search for a new Chief Financial Officer  Paris, July 30th, 2025 — The Group announces today that Jean‑Christophe Juillard will …

Nexans annonce le départ de son Directeur Général Adjoint et Directeur Financier, et lance la recherche d’un successeur pour le poste de Directeur Financier

Nexans annonce le départ de son Directeur Général Adjoint et Directeur Financier, et lance la recherche d’un successeur pour le poste de Directeur Financier

Paris, le 30 juillet 2025 – Nexans annonce aujourd'hui que Jean-Christophe Juillard quittera ses fonctions de Directeur Général Adjoint et Directeur Financier dans les prochains mois. Avec sa contribution, Nexans a significativement amélioré sa …

H1 2025: Outstanding delivery of Nexans’ model, 2025 guidance upgraded

H1 2025: Outstanding delivery of Nexans’ model, 2025 guidance upgraded

H1 2025: Outstanding delivery of Nexans’ model +4.9% organic growth driven by the performance of our Electrification businesses (+7.8% organic growth) Record EBITDA and ongoing margin improvements Lynxeo disposal successfully completed 2025 guidance …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions